{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,11]],"date-time":"2026-11-11T21:55:49Z","timestamp":1794434149096,"version":"4.9.1"},"reference-count":32,"publisher":"Springer Science and Business Media LLC","issue":"8","license":[{"start":{"date-parts":[[2024,7,4]],"date-time":"2024-07-04T00:00:00Z","timestamp":1720051200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2024,7,4]],"date-time":"2024-07-04T00:00:00Z","timestamp":1720051200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","award":["T32HL076132"],"award-info":[{"award-number":["T32HL076132"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","award":["R01HL146754"],"award-info":[{"award-number":["R01HL146754"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]},{"name":"Cleveland Clinic Philanthropy Institute\u2019s Caregiver Catalyst Grant"},{"name":"Cleveland Clinic Musculoskeletal Research Center\u2019s Pilot Project Program Grant"},{"DOI":"10.13039\/100001491","name":"Belgian American Educational Foundation","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100001491","id-type":"DOI","asserted-by":"publisher"}]},{"name":"Frans Van de Werf Fund"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Int J Cardiovasc Imaging"],"abstract":"<jats:title>Abstract<\/jats:title><jats:p>Given the critical role of skeletal muscle in healthy aging, low muscle mass (myopenia) and quality (myosteatosis) can be used as predictors of poor functional and cardiometabolic outcomes. Myopenia is also a part of sarcopenia and malnutrition diagnostic criteria. However, there is limited evidence for using chest computed tomography (CT) to evaluate muscle health. We aimed to compare chest CT landmarks to the widely used L3 vertebra for single-slice skeletal muscle evaluation in patients with heart failure (HF). Patients admitted for acute decompensated HF between January 2017 and December 2018 were retrospectively analyzed. Body composition measurements were made on CT of the chest and abdomen\/pelvis with or without contrast one month before discharge. Skeletal muscle index (SMI) and intermuscular adipose tissue percentage (IMAT%) were calculated at several thoracic levels (above the aortic arch, T8, and T12) and correlated to the widely used L3 level. A total of 200 patients were included, 89 (44.5%) female. The strongest correlation of thoracic SMI (for muscle quantity) and IMAT% (for muscle quality) with L3 was at the T12 level (<jats:italic>r<\/jats:italic>\u2009=\u20090.834, <jats:italic>p<\/jats:italic>\u2009&lt;\u20090.001 and <jats:italic>r<\/jats:italic>\u2009=\u20090.757, <jats:italic>p<\/jats:italic>\u2009&lt;\u20090.001, respectively). Cutoffs to identify low muscle mass for T12 SMI (derived from the lowest sex-stratified L3 SMI tertile) were 31.1\u00a0cm\u00b2\/m\u00b2 in men and 26.3\u00a0cm\u00b2\/m\u00b2 in women. SMI and IMAT% at T12 had excellent correlations with the widely used L3 level for muscle quantity and quality evaluation in patients with HF.<\/jats:p>","DOI":"10.1007\/s10554-024-03169-w","type":"journal-article","created":{"date-parts":[[2024,7,4]],"date-time":"2024-07-04T12:01:40Z","timestamp":1720094500000},"page":"1787-1796","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":12,"title":["Skeletal muscle quantity and quality evaluation in heart failure: comparing thoracic versus abdominopelvic CT approaches"],"prefix":"10.1007","volume":"40","author":[{"given":"Saeid","family":"Mirzai","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ian","family":"Persits","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Pieter","family":"Martens","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jerry D.","family":"Estep","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"W. H.","family":"Wilson Tang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Po-Hao","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2024,7,4]]},"reference":[{"key":"3169_CR1","doi-asserted-by":"publisher","unstructured":"Rezu\u015f E, Burlui A, Cardoneanu A et al (2020) Inactivity and skeletal muscle metabolism: a vicious cycle in old age. Int J Mol Sci 21. https:\/\/doi.org\/10.3390\/ijms21020592","DOI":"10.3390\/ijms21020592"},{"key":"3169_CR2","doi-asserted-by":"publisher","first-page":"1","DOI":"10.3390\/cells11010160","volume":"11","author":"J Bilski","year":"2022","unstructured":"Bilski J, Pierzchalski P, Szczepanik M et al (2022) Multifactorial mechanism of Sarcopenia and Sarcopenic Obesity. Role of Physical Exercise, Microbiota and Myokines. Cells 11:1\u201341. https:\/\/doi.org\/10.3390\/cells11010160","journal-title":"Cells"},{"key":"3169_CR3","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1007\/s13539-011-0025-7","volume":"2","author":"K Fearon","year":"2011","unstructured":"Fearon K, Evans WJ, Anker SD (2011) Myopenia-a new universal term for muscle wasting. J Cachexia Sarcopenia Muscle 2:1\u20133. https:\/\/doi.org\/10.1007\/s13539-011-0025-7","journal-title":"J Cachexia Sarcopenia Muscle"},{"key":"3169_CR4","doi-asserted-by":"publisher","first-page":"675","DOI":"10.1080\/07853890.2018.1511918","volume":"50","author":"CM Prado","year":"2018","unstructured":"Prado CM, Purcell SA, Alish C et al (2018) Implications of low muscle mass across the continuum of care: a narrative review. Ann Med 50:675\u2013693. https:\/\/doi.org\/10.1080\/07853890.2018.1511918","journal-title":"Ann Med"},{"key":"3169_CR5","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.clnu.2018.08.002","volume":"38","author":"T Cederholm","year":"2019","unstructured":"Cederholm T, Jensen GL, Correia MITD et al (2019) GLIM criteria for the diagnosis of malnutrition \u2013 A consensus report from the global clinical nutrition community. Clin Nutr 38:1\u20139. https:\/\/doi.org\/10.1016\/j.clnu.2018.08.002","journal-title":"Clin Nutr"},{"key":"3169_CR6","doi-asserted-by":"publisher","DOI":"10.1161\/CIRCHEARTFAILURE.121.009322","author":"S Mirzai","year":"2022","unstructured":"Mirzai S, Eck BL, Chen P-H et al (2022) Current Approach to the diagnosis of Sarcopenia in Heart failure: a narrative review on the Role of Clinical and Imaging assessments. Circ Heart Fail. https:\/\/doi.org\/10.1161\/CIRCHEARTFAILURE.121.009322. 101161CIRCHEARTFAILURE121009322","journal-title":"Circ Heart Fail"},{"key":"3169_CR7","doi-asserted-by":"publisher","first-page":"1269","DOI":"10.1002\/jcsm.12372","volume":"9","author":"BC Clark","year":"2018","unstructured":"Clark BC, Tavoian D, Goodpaster BH et al (2018) Comment on: pitfalls in the measurement of muscle mass: a need for a reference standard by Buckinx et al. J Cachexia Sarcopenia Muscle 9:1269\u20131271. https:\/\/doi.org\/10.1002\/jcsm.12372","journal-title":"J Cachexia Sarcopenia Muscle"},{"key":"3169_CR8","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/s12877-021-02187-w","volume":"21","author":"H Oba","year":"2021","unstructured":"Oba H, Matsui Y, Arai H et al (2021) Evaluation of muscle quality and quantity for the assessment of Sarcopenia using mid-thigh computed tomography: a cohort study. BMC Geriatr 21:1\u20138. https:\/\/doi.org\/10.1186\/s12877-021-02187-w","journal-title":"BMC Geriatr"},{"key":"3169_CR9","doi-asserted-by":"publisher","first-page":"2333","DOI":"10.1152\/japplphysiol.00744.2004","volume":"97","author":"W Shen","year":"2004","unstructured":"Shen W, Punyanitya M, Wang ZM et al (2004) Total body skeletal muscle and adipose tissue volumes: estimation from a single abdominal cross-sectional image. J Appl Physiol 97:2333\u20132338. https:\/\/doi.org\/10.1152\/japplphysiol.00744.2004","journal-title":"J Appl Physiol"},{"key":"3169_CR10","doi-asserted-by":"publisher","first-page":"2199","DOI":"10.1007\/s00330-019-06573-2","volume":"30","author":"D Albano","year":"2020","unstructured":"Albano D, Messina C, Vitale J, Sconfienza LM (2020) Imaging of Sarcopenia: old evidence and new insights. Eur Radiol 30:2199\u20132208. https:\/\/doi.org\/10.1007\/s00330-019-06573-2","journal-title":"Eur Radiol"},{"key":"3169_CR11","doi-asserted-by":"publisher","first-page":"16","DOI":"10.1093\/ageing\/afy169","volume":"48","author":"AJ Cruz-Jentoft","year":"2019","unstructured":"Cruz-Jentoft AJ, Bahat G, Bauer J et al (2019) Sarcopenia: revised European consensus on definition and diagnosis. Age Ageing 48:16\u201331. https:\/\/doi.org\/10.1093\/ageing\/afy169","journal-title":"Age Ageing"},{"key":"3169_CR12","doi-asserted-by":"publisher","first-page":"109879","DOI":"10.1016\/j.ejrad.2021.109879","volume":"142","author":"HC van Heusden","year":"2021","unstructured":"van Heusden HC, Swartz JE, Chargi N et al (2021) Feasibility of assessment of skeletal muscle mass on a single cross-sectional image at the level of the fourth thoracic vertebra. Eur J Radiol 142:109879. https:\/\/doi.org\/10.1016\/j.ejrad.2021.109879","journal-title":"Eur J Radiol"},{"key":"3169_CR13","doi-asserted-by":"publisher","first-page":"42","DOI":"10.21037\/atm.2018.01.13","volume":"6","author":"A Milinovich","year":"2018","unstructured":"Milinovich A, Kattan MW (2018) Extracting and utilizing electronic health data from Epic for research. Ann Transl Med 6:42\u201342. https:\/\/doi.org\/10.21037\/atm.2018.01.13","journal-title":"Ann Transl Med"},{"key":"3169_CR14","doi-asserted-by":"publisher","first-page":"1258","DOI":"10.1002\/jcsm.12573","volume":"11","author":"EM Cespedes Feliciano","year":"2020","unstructured":"Cespedes Feliciano EM, Popuri K, Cobzas D et al (2020) Evaluation of automated computed tomography segmentation to assess body composition and mortality associations in cancer patients. J Cachexia Sarcopenia Muscle 11:1258\u20131269. https:\/\/doi.org\/10.1002\/jcsm.12573","journal-title":"J Cachexia Sarcopenia Muscle"},{"key":"3169_CR15","doi-asserted-by":"publisher","unstructured":"Marasco G, Sadalla S, Vara G et al (2021) Imaging Software-Based Sarcopenia Assessment in Gastroenterology: Evolution and Clinical Meaning. Can J Gastroenterol Hepatol 2021:. https:\/\/doi.org\/10.1155\/2021\/6669480","DOI":"10.1155\/2021\/6669480"},{"key":"3169_CR16","doi-asserted-by":"publisher","first-page":"643","DOI":"10.3904\/kjim.2016.015","volume":"31","author":"KM Kim","year":"2016","unstructured":"Kim KM, Jang HC, Lim S (2016) Differences among skeletal muscle mass indices derived from height-, weight-, and body mass index-adjusted models in assessing Sarcopenia. Korean J Intern Med 31:643\u2013650. https:\/\/doi.org\/10.3904\/kjim.2016.015","journal-title":"Korean J Intern Med"},{"key":"3169_CR17","doi-asserted-by":"publisher","first-page":"629","DOI":"10.1016\/S1470-2045(08)70153-0","volume":"9","author":"CM Prado","year":"2008","unstructured":"Prado CM, Lieffers JR, McCargar LJ et al (2008) Prevalence and clinical implications of sarcopenic obesity in patients with solid tumours of the respiratory and gastrointestinal tracts: a population-based study. Lancet Oncol 9:629\u2013635. https:\/\/doi.org\/10.1016\/S1470-2045(08)70153-0","journal-title":"Lancet Oncol"},{"key":"3169_CR18","doi-asserted-by":"publisher","first-page":"1","DOI":"10.3389\/fmed.2021.743698","volume":"8","author":"X Jing","year":"2021","unstructured":"Jing X, Tan L, Fu H et al (2021) Associations of ADL disability with trunk muscle Mass and muscle quality indicators measured by opportunistic chest computed Tomography Imaging among older inpatients. Front Med 8:1\u20139. https:\/\/doi.org\/10.3389\/fmed.2021.743698","journal-title":"Front Med"},{"key":"3169_CR19","doi-asserted-by":"publisher","first-page":"2636","DOI":"10.1016\/S0140-6736(19)31138-9","volume":"393","author":"AJ Cruz-Jentoft","year":"2019","unstructured":"Cruz-Jentoft AJ, Sayer AA (2019) Sarcopenia Lancet 393:2636\u20132646. https:\/\/doi.org\/10.1016\/S0140-6736(19)31138-9","journal-title":"Sarcopenia Lancet"},{"key":"3169_CR20","doi-asserted-by":"publisher","first-page":"1610","DOI":"10.1111\/tri.13749","volume":"33","author":"D Rozenberg","year":"2020","unstructured":"Rozenberg D, Orsso CE, Chohan K et al (2020) Clinical outcomes associated with computed tomography-based body composition measures in lung transplantation: a systematic review. Transpl Int 33:1610\u20131625. https:\/\/doi.org\/10.1111\/tri.13749","journal-title":"Transpl Int"},{"key":"3169_CR21","doi-asserted-by":"publisher","first-page":"1154","DOI":"10.1016\/j.acra.2017.02.008","volume":"24","author":"U Nemec","year":"2017","unstructured":"Nemec U, Heidinger B, Sokas C et al (2017) Diagnosing Sarcopenia on thoracic computed tomography: quantitative Assessment of skeletal muscle Mass in patients undergoing transcatheter aortic valve replacement. Acad Radiol 24:1154\u20131161. https:\/\/doi.org\/10.1016\/j.acra.2017.02.008","journal-title":"Acad Radiol"},{"key":"3169_CR22","doi-asserted-by":"publisher","first-page":"1","DOI":"10.3390\/life11020086","volume":"11","author":"CM Lee","year":"2021","unstructured":"Lee CM, Kang BK, Kim M (2021) Radiologic definition of Sarcopenia in chronic liver disease. Life 11:1\u201316. https:\/\/doi.org\/10.3390\/life11020086","journal-title":"Life"},{"key":"3169_CR23","doi-asserted-by":"publisher","first-page":"308","DOI":"10.1016\/j.cardfail.2019.11.021","volume":"26","author":"R Cogswell","year":"2020","unstructured":"Cogswell R, Trachtenberg B, Murray T et al (2020) A Novel Model incorporating Pectoralis muscle measures to Predict Mortality after ventricular assist device implantation: the Minnesota Pectoralis Risk score. J Card Fail 26:308\u2013315. https:\/\/doi.org\/10.1016\/j.cardfail.2019.11.021","journal-title":"J Card Fail"},{"key":"3169_CR24","doi-asserted-by":"publisher","first-page":"203","DOI":"10.1016\/j.jcmg.2020.07.022","volume":"14","author":"S Selvaraj","year":"2021","unstructured":"Selvaraj S, Kim J, Ansari BA et al (2021) Body composition, Natriuretic Peptides, and adverse outcomes in heart failure with preserved and reduced ejection fraction. JACC Cardiovasc Imaging 14:203\u2013215. https:\/\/doi.org\/10.1016\/j.jcmg.2020.07.022","journal-title":"JACC Cardiovasc Imaging"},{"key":"3169_CR25","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/s12933-016-0370-0","volume":"15","author":"FY Huang","year":"2016","unstructured":"Huang FY, Wang H, Huang BT et al (2016) The influence of body composition on the N-terminal pro-B-type natriuretic peptide level and its prognostic performance in patients with acute coronary syndrome: a cohort study. Cardiovasc Diabetol 15:1\u201311. https:\/\/doi.org\/10.1186\/s12933-016-0370-0","journal-title":"Cardiovasc Diabetol"},{"key":"3169_CR26","doi-asserted-by":"publisher","first-page":"339","DOI":"10.1016\/j.amjcard.2023.08.136","volume":"207","author":"S Mirzai","year":"2023","unstructured":"Mirzai S, Persits I, Martens P et al (2023) Significance of adipose tissue quantity and distribution on obesity Paradox in Heart failure. Am J Cardiol 207:339\u2013348. https:\/\/doi.org\/10.1016\/j.amjcard.2023.08.136","journal-title":"Am J Cardiol"},{"key":"3169_CR27","doi-asserted-by":"publisher","first-page":"2163","DOI":"10.1161\/CIRCULATIONAHA.105.555573","volume":"112","author":"SR Das","year":"2005","unstructured":"Das SR, Drazner MH, Dries DL et al (2005) Impact of body mass and body composition on circulating levels of natriuretic peptides: results from the Dallas Heart Study. Circulation 112:2163\u20132168. https:\/\/doi.org\/10.1161\/CIRCULATIONAHA.105.555573","journal-title":"Circulation"},{"key":"3169_CR28","doi-asserted-by":"publisher","first-page":"90","DOI":"10.1016\/j.jamda.2018.06.011","volume":"20","author":"K Uemura","year":"2019","unstructured":"Uemura K, Doi T, Lee S, Shimada H (2019) Sarcopenia and low serum albumin level synergistically increase the risk of Incident Disability in older adults. J Am Med Dir Assoc 20:90\u201393. https:\/\/doi.org\/10.1016\/j.jamda.2018.06.011","journal-title":"J Am Med Dir Assoc"},{"key":"3169_CR29","doi-asserted-by":"publisher","first-page":"1651","DOI":"10.1016\/j.jvs.2021.04.054","volume":"74","author":"I Lindstr\u00f6m","year":"2021","unstructured":"Lindstr\u00f6m I, Protto S, Khan N et al (2021) Statin use, development of Sarcopenia, and long-term survival after endovascular aortic repair. J Vasc Surg 74:1651\u20131658e1. https:\/\/doi.org\/10.1016\/j.jvs.2021.04.054","journal-title":"J Vasc Surg"},{"key":"3169_CR30","doi-asserted-by":"publisher","first-page":"237","DOI":"10.1002\/jcsm.12654","volume":"12","author":"H Mollazadeh","year":"2021","unstructured":"Mollazadeh H, Tavana E, Fanni G et al (2021) Effects of statins on mitochondrial pathways. J Cachexia Sarcopenia Muscle 12:237\u2013251. https:\/\/doi.org\/10.1002\/jcsm.12654","journal-title":"J Cachexia Sarcopenia Muscle"},{"key":"3169_CR31","doi-asserted-by":"publisher","first-page":"1177","DOI":"10.1002\/jcsm.12579","volume":"11","author":"A Sahebkar","year":"2020","unstructured":"Sahebkar A, Cicero AFG, Di Giosia P et al (2020) Pathophysiological mechanisms of statin-associated myopathies: possible role of the ubiquitin-proteasome system. J Cachexia Sarcopenia Muscle 11:1177\u20131186. https:\/\/doi.org\/10.1002\/jcsm.12579","journal-title":"J Cachexia Sarcopenia Muscle"},{"key":"3169_CR32","doi-asserted-by":"publisher","first-page":"367","DOI":"10.1017\/S0029665115002438","volume":"74","author":"S Von Haehling","year":"2015","unstructured":"Von Haehling S (2015) The wasting continuum in heart failure: from sarcopenia to cachexia. Proc Nutr Soc 74:367\u2013377. https:\/\/doi.org\/10.1017\/S0029665115002438","journal-title":"Proc Nutr Soc"}],"container-title":["The International Journal of Cardiovascular Imaging"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s10554-024-03169-w.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s10554-024-03169-w\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s10554-024-03169-w.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,9,14]],"date-time":"2024-09-14T04:05:46Z","timestamp":1726286746000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s10554-024-03169-w"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,7,4]]},"references-count":32,"journal-issue":{"issue":"8","published-online":{"date-parts":[[2024,8]]}},"alternative-id":["3169"],"URL":"https:\/\/doi.org\/10.1007\/s10554-024-03169-w","relation":{},"ISSN":["1875-8312"],"issn-type":[{"value":"1875-8312","type":"electronic"}],"subject":[],"published":{"date-parts":[[2024,7,4]]},"assertion":[{"value":"13 March 2024","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"22 June 2024","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"4 July 2024","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The Cleveland Clinic Institutional Review Board approved this study. Given the retrospective design, the need for written informed consent was waived.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethical approval"}},{"value":"Dr. Martens has received consultancy fees from AstraZeneca, Abbott, Bayer, Boehringer-Ingelheim, Daiichi Sankyo, Novartis, Novo Nordisk, and Vifor Pharma. Dr. Estep is a consultant for Abbott, Getinge, and BioVentrix. Dr. Tang serves as a consultant to Sequana Medical, Cardiol Therapeutics, Genomics plc, Renovacor, Zehna Therapeutics, Boston Scientific, Kiniksa Pharmaceuticals, WhiteSwell, CardiaTec Biosciences, Intellia Therapeutics, and received honoraria from Springer, Belvoir Media Group, and American Board of Internal Medicine - all unrelated to the topic of study. All other authors have no relationships to disclose.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}]}}